Nebula Research & Development LLC Trans Medics Group, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 4,827 shares of TMDX stock, worth $654,492. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,827Holding current value
$654,492% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding TMDX
# of Institutions
338Shares Held
32.1MCall Options Held
852KPut Options Held
690K-
Vanguard Group Inc Valley Forge, PA3.57MShares$485 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL3.11MShares$422 Million0.06% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$359 Million0.01% of portfolio
-
State Street Corp Boston, MA1.31MShares$177 Million0.0% of portfolio
-
Fil LTD Hamilton, D01.23MShares$166 Million0.09% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.32B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...